To Investigate the Effect of Yougui Pill on Bone Density and the Expression Levels of Β-Catenin, DKK-1 and MMP-9 in Patients with Osteoporotic Thoracolumbar Compression Fracture

Y. Zhong,B. Dong,P. Yuan,J. Yao,Z. Wang,W. Kang
DOI: https://doi.org/10.1016/j.joca.2021.02.306
IF: 7.507
2021-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: To investigate the clinical effect and mechanism of Yougui pill on osteoporotic thoracolumbar compression fracture. Methods: Seventy-eight patients with osteoporotic thoracolumbar compression fractures were selected and randomly divided into a control group and an observation group, with 39 cases in each group. Both groups were treated by the same physician with either percutaneous balloon dilatation vertebroplasty (PKP) or percutaneous puncture vertebroplasty (PVP), depending on the fracture. The control group was given oral alendronate, 10 mg of alendronate at bedtime every night, once/d.The observation group was orally treated with alendronate sodium combined with Yougui pill, 9 g/time and 3 times/day, and both groups were treated for 1 month. Changes in the serum expression levels of β-catenin, DKK-1, and MMP-9 in both groups of patients before and after treatment and changes in bone density and bone metabolism markers PINP and MID levels 3 months after surgery were recorded. Results: The expression of β-catenin DKK-1 and MMP-9 protein in both groups before treatment (P>0.05); after treatment, the expression of DKK-1 and MMP-9 protein in both groups decreased compared with that in the present group (P<0.05), and the decrease was more obvious in the observation group (P<0.05). before treatment, β-catenin protein expression in both groups (P>0.05); after treatment, β-catenin protein expression was significantly increased in both groups (P<0.05), and the increase was more pronounced in the post-treatment observation group than in the control group (P<0.05). The difference in bone density between the two groups on the first postoperative day was not statistically significant (P>0.05); the bone density of the two groups increased significantly 3 months after surgery compared with the first postoperative day (P<0.05), and the observation group was significantly higher than the control group (P<0.05).The difference in serum PINP and MID levels between the two groups on postoperative day 1 was not statistically significant (P>0.05); the two groups were significantly lower at 3 months postoperatively than on postoperative day 1 (P<0.05), and the observation group was significantly lower than the control group (P<0.05). Conclusions: Yougui pill combined with alendronate is effective in menopausal patients with osteoporotic vertebral compression fractures, increasing bone density, improving bone metabolism and promoting fracture healing.The mechanism of action may be related to the inhibition of DKK-1 and MMP-9 protein expression and activation of β-catenin protein expression.View Large Image Figure ViewerDownload Hi-res image Download (PPT)View Large Image Figure ViewerDownload Hi-res image Download (PPT)
What problem does this paper attempt to address?